Home Cart Sign in  
Chemical Structure| 55-97-0 Chemical Structure| 55-97-0

Structure of Hexamethonium Bromide
CAS No.: 55-97-0

Chemical Structure| 55-97-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hexamethonium bromide is a nicotinic cholinergic antagonist as the prototypical ganglionic blocker.

Synonyms: Hexamethonium (bromide)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hexamethonium Bromide

CAS No. :55-97-0
Formula : C12H30Br2N2
M.W : 362.19
SMILES Code : C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-]
Synonyms :
Hexamethonium (bromide)
MDL No. :MFCD00011787

Safety of Hexamethonium Bromide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H373
Precautionary Statements:P260-P314-P501

Isoform Comparison

Biological Activity

Target
  • AChR

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Neuropathic pain model Intravenous injection 30 mg/kg Single dose, 15 min before IR surgery To investigate the effect of hexamethonium bromide on neuropathic pain-induced cardioprotection. Results showed that hexamethonium bromide abolished the SNI-induced cardioprotection. Nat Commun. 2017 Oct 10;8(1):826
Female Danish landrace pigs Anesthetized pig model Intravenous injection 8 mg/kg Two injections, interval not specified To evaluate the effect of hexamethonium on GLP-1-induced heart rate increase, results showed that GLP-1 still increased heart rate even after hexamethonium administration Cardiovasc Res. 2024 Oct 14;120(12):1427-1441
Spontaneously Hypertensive Rats (SHR) Spontaneously Hypertensive Rat Model Intravenous injection 20 mg/kg BW Single dose Assessed indirect sympathetic nervous system activity, showing enhanced depressor response in SHRs, which was restored to normal levels after TLR4 blockade. Pharmacol Res. 2021 Dec;174:105877
Mice Smooth muscle-specific STIM1 knockout mice Intraperitoneal injection 5 mg/kg Single injection To study the effect of STIM1 deletion on blood pressure, results showed that STIM1 knockout mice had a more pronounced reduction in BP after sympathetic blockade Cardiovasc Res. 2018 Apr 1;114(5):668-678
Rats Ischemia-reperfusion injury model Perfusion 50 μM 5 minutes pretreatment and during dialysate perfusion To investigate the effect of hexamethonium bromide on remote ischemic conditioning (RIC)-mediated cardioprotection. Results showed that 50 μM hexamethonium bromide abrogated the cardioprotection mediated by RIC dialysate. Basic Res Cardiol. 2016 Jul;111(4):50
Male Sprague-Dawley rats Isolated perfused rat heart model Perfusion 50 μM 5 min prior to and during the 3-cycle preconditioning To investigate the role of hexamethonium bromide in ischemic preconditioning, results showed that hexamethonium bromide blocked the protective effect of IPC. Basic Res Cardiol. 2017 Mar;112(2):11
Male Wistar rats Pithed rat model Intravenous infusion 2 mg/kg·min Continuous infusion To block the electrically-induced vasopressor responses J Headache Pain. 2018 May 25;19(1):40
BPH/2J mice Genetically hypertensive model Intraperitoneal injection 10 mg/kg Measured on control day 3 and postoperative day 10 To measure global neurogenic pressor activity. The depressor response to hexamethonium in the RDNX group was significantly smaller on postoperative day 10 compared with baseline control, whereas no such effect was observed in SHAM or CGX groups. Hypertension. 2021 Feb;77(2):519-528

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03360136 Exhaustion; Syndrome ... More >> Burnout, Professional Burnout Syndrome Adjustment Disorders Less << Not Applicable Recruiting July 1, 2020 Sweden ... More >> PBM Sweden AB Globen Recruiting Stockholm, Södermanland, Sweden, 12177 Contact: Gunilla Brodda Jansen, Assoc. Proff.    070-716 39 13 ext +46    gunillabroddajansen@pbm.se    PBM Sweden City Recruiting Stockholm, Uppland, Sweden, 114 47 Contact: Gunilla Brodda Jansen, Assoc. Proff.    070-716 39 13 ext +46    gunillabroddajansen@pbm.se Less <<
NCT03468114 Enteric Infections ... More >> Diarrhea Less << Not Applicable Recruiting December 2018 Kenya ... More >> Great Lakes University Kisumu Recruiting Kisumu, Kenya Contact: Sheillah Simiyu, PhD    +254 722 215291    sheillahshie@gmail.com Less <<
NCT01626703 Depression Sc... More >>reening Elderly Less << Not Applicable Completed - Korea, Republic of ... More >> Chungju community health care center Chungju, Choongbuk, Korea, Republic of, 123456 Less <<
NCT02053649 Depression Ma... More >>jor Depressive Disorder Postpartum Depression Less << Not Applicable Recruiting - United States, Rhode Island ... More >> Miriam Hospital Women's Medicine Collaborative Recruiting Providence, Rhode Island, United States, 02904 Sub-Investigator: Teri Pearlstein, MD Less <<
NCT01945814 EBV CMV ... More >> Adenovirus Less << Phase 1 Recruiting September 2020 United States, District of Col... More >>umbia Childrens National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Fahmida Hoq, MBBS, MS    202-476-3634    fhoq@cnmc.org Less <<
NCT03180216 Viral Infections ... More >> Bone Marrow Transplant Infection Less << Phase 1 Recruiting August 2021 United States, District of Col... More >>umbia Childrens National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Fahmida Hoq, MBBS, MS    202-476-3634    fhoq@cnmc.org    Contact: Catherine Bollard, MD    202-476-4776 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.76mL

0.55mL

0.28mL

13.80mL

2.76mL

1.38mL

27.61mL

5.52mL

2.76mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories